MG
BSX icon

Michael Gelband’s Boston Scientific BSX Stock Holding History

Michael Gelband’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,000
Closed -$1.57M – 1605
2026
Q1 		$1.57M Buy
+25,000
New +$2M 0.01% 863
2021
Q1 		– Sell
-115,100
Closed -$4.14M – 2136
2020
Q4 		$4.14M Buy
+115,100
New +$4.15M 0.04% 301

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's BSX Position: Q2 2026 in Review

Michael Gelband increased its Boston Scientific (BSX) stake by 62% in Q2 2026, buying an estimated $10.5M and bringing the position to 504,948 shares worth $21.6M. The position accounts for 0.14% of the portfolio, ranked #116.

Michael Gelband first reported a position in BSX in Q3 2019 and has held it in 24 quarters since. The position peaked at $84.1M in Q3 2024. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Michael Gelband held 504,948 shares of Boston Scientific worth $21.6M as of Q2 2026.
  • Michael Gelband bought 193,585 Boston Scientific shares in Q2 2026, an estimated $10.5M.
  • Boston Scientific made up 0.14% of Michael Gelband's portfolio in Q2 2026, its #116 holding.
  • Michael Gelband first reported a position in Boston Scientific in Q3 2019 and has held it in 24 quarters since.
  • Michael Gelband's Boston Scientific position peaked at $84.1M in Q3 2024.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.